The company that turned "fair market value" from a shrug into a defensible number - and built the world's largest specialty-specific rate database doing it.
// The 512-pixel logo of a firm whose actual product is a 230,000-row answer to a question most people never think to ask: what is an hour of a doctor's expertise worth?
Somewhere right now, a pharmaceutical compliance officer is staring at a contract for a cardiologist in Brazil. The doctor is brilliant. The advisory board needs her. The only question is the one nobody can answer off the top of their head: how much is she allowed to be paid? Pay too little and she walks. Pay too much and a regulator comes knocking. The officer opens a tool, types in a few details, and gets a number. That number came from Cutting Edge Information.
CEI is a market research and data analytics firm in Research Triangle Park, North Carolina. Its single obsession is Fair Market Value - the rate a healthcare professional can legitimately be paid for an hour of their time. The company has turned that obsession into a database of more than 230,000 real-world observations, covering 280-plus specialties across 126 countries. More than 300 companies pay to use it, including over 70% of the top 25 pharmaceutical firms and 8 of the top 10.
Above: not a metaphor. The actual daily workflow of a global compliance team, compressed into one sentence.
For years, the life sciences industry priced healthcare professionals the way you'd haggle at a flea market - a little intuition, a little internal precedent, a lot of hope that nobody would ask for the math later. The trouble is that someone always asks for the math later. Anti-bribery laws, transparency reporting, and the simple optics of paying doctors mean every dollar has to be both competitive and defensible. Those two goals usually point in opposite directions.
Set rates too low and the best clinical minds take their time elsewhere. Set them too high and you have handed a regulator a story about influence-buying. The middle - the genuinely fair number - was historically a matter of opinion. And opinions, it turns out, do not hold up well under audit.
CEI's bet was that "fair" should not be an opinion at all. It should be a measurement - specialty-specific, country-specific, and backed by what people are actually paid. Refreshingly unglamorous, and exactly the sort of thing a regulator likes to see.
Cutting Edge Information did not begin life as an FMV company. It launched in 2002 as a general market research firm - the kind that could research nearly anything and, like most generalists, owned nearly nothing. By 2005, the leadership made a decision that looked narrow at the time and shrewd in hindsight: stop researching everything, and specialize entirely in Fair Market Value data.
Chairman Steven F. Maier brought the long view. A former 18-year faculty member at Duke's Fuqua School of Business, he has been involved with roughly 30 startups and acquisitions, which is to say he has a healthy respect for the difference between a busy company and a valuable one. Eric Bolesh, one of the firm's founding employees and now CEO, brought the other half: two decades of staying in the room with clients while they wrestled real FMV decisions into compliant contracts.
The bet, plainly stated: a firm that does one thing beats a firm that does forty. The market eventually agreed.
CEI opens as a general market research firm serving the life sciences industry.
The company narrows its focus and commits to FMV data as its core function, not a side service.
Launches with 5,100 data points - described as the first attempt at a consistent global FMV database built on actual hourly rates paid to HCPs.
Named a leading pharma compliance and FMV solutions provider by Pharma Tech Outlook and Life Sciences Review.
The database spans 280+ specialties and roles and serves 8 of the top 10 pharmaceutical companies.
What CEI sells is deceptively simple: confidence. Behind it sit three products that turn a sprawling database into something a busy team can actually use.
The worldwide, specialty-specific rate database itself - built from actual hourly rates and refreshed continuously.
Turns the database into a defensible offer in seconds, with adjustments for travel time, virtual vs in-person, and cross-border work.
Expert guidance, benchmarking, and best practices that help teams deploy rates and reduce compliance risk.
CEI claims to be the only company offering worldwide FMV rates that are specialty-specific - meaning a neurosurgeon in Germany and a general practitioner in the Philippines are not lumped into the same bucket and hoped for the best. The distinction sounds pedantic until you are the one signing the contract.
Skepticism is the correct posture toward any company that says it has solved an unsolvable problem. So here is the evidence, such as it is, in the only language compliance teams trust: data.
FMV data points in the database, by year
Source: CEI company statements. 2020 figure is an illustrative midpoint between the verified 2015 and 2025 totals.
The client roster is the harder evidence. Winning over 70% of the top 25 pharmaceutical companies - the most compliance-anxious buyers on Earth - is not a thing you do with marketing. You do it by being right, repeatedly, in front of auditors. One client described the team as "a true partner and a true extension of our team," which is the sort of thing buyers say only when the vendor has stopped feeling like a vendor.
Chart note: the 2015 bar is genuinely that small. Growth this steep usually signals either a bubble or a real need. This was the second kind.
CEI's mission reads less like a manifesto and more like a quietly ambitious engineering spec: deliver the world's most accurate, market-based FMV data so companies can engage healthcare professionals at rates that are both competitive and compliant. No talk of changing the world. Just a stubborn insistence that a number meant to be fair should be backed by evidence.
The work matters because the stakes behind it are not abstract. Behind every FMV rate is a real decision about whether the right expert gets to advise on a real medicine. Price expertise wrong and you either lose the expert or invite the regulator - and somewhere downstream, the science gets a little worse.
The questions CEI answers are multiplying. Virtual advisory boards versus in-person ones. Cross-border engagements that touch three regulatory regimes at once. Influencer-style HCP compensation that did not exist a decade ago. Transparency rules that keep tightening. Each new wrinkle is one more thing nobody can price from intuition - and one more reason to consult a database built for exactly this.
Back to that compliance officer and the cardiologist in Brazil. Before CEI, that contract would have been an argument: a guess defended with conviction and crossed fingers. Now it is a lookup. The officer types in the specialty, the country, the format, the travel time. A defensible number comes back. The advisory board gets its expert. The auditor gets her math. And the question that used to stop a deal cold has become the easiest part of the afternoon.
Final frame: same desk, same cardiologist, same contract. The only thing that changed is that the hardest question now takes thirty seconds.